Fabrice Journé
- Sensory Systems top 1%
- Olfactory and Sensory Function Studies 7
- Oncology top 2%
- Bone health and treatments 17
- Cancer-related Molecular Pathways 8
- Cutaneous Melanoma Detection and Management 6
- Cancer Immunotherapy and Biomarkers 6
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 9
- Immunology top 5%
- Cancer Research top 5%
-
- Estrogen and related hormone effects 15
-
- Melanoma and MAPK Pathways 14
- Co-authors
- Sven SaussezGhanem GhanemJérôme R. LechienJean‐Jacques BodyGuy LaurentNadège KindtDenis NonclercqGéraldine Descamps
- Journals
- Nature Communications (1 paper)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)
In The Last Decade
Fabrice Journé
110 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 123
- Sensory Systems 376
- Oncology 1.1k
- Otorhinolaryngology 150
- Immunology 616
- Cancer Research 392
Countries citing papers authored by Fabrice Journé
This map shows the geographic impact of Fabrice Journé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Journé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Journé more than expected).
Fields of papers citing papers by Fabrice Journé
This network shows the impact of papers produced by Fabrice Journé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Journé. The network helps show where Fabrice Journé may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fabrice Journé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 11 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 16 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 35 | |
| 14 | 2021 | 15 | |
| 15 | 2020 | 15 | |
| 16 | 2019 | 20 | |
| 17 | 2019 | 42 | |
| 18 | 2017 | 91 | |
| 19 | 2017 | 41 | |
| 20 | 2010 | 69 |
About Fabrice Journé
Fabrice Journé is a scholar working on Oncology, Otorhinolaryngology and Sensory Systems, having authored 113 papers that have together received 3.3k indexed citations. Recurring topics across this work include Bone health and treatments (17 papers), Estrogen and related hormone effects (15 papers), Melanoma and MAPK Pathways (14 papers), Head and Neck Cancer Studies (9 papers), Cancer-related Molecular Pathways (8 papers), Olfactory and Sensory Function Studies (7 papers), Cutaneous Melanoma Detection and Management (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Sensory Systems (376 citations), Oncology (1.1k citations) and Otorhinolaryngology (150 citations). Fabrice Journé has collaborated with scholars based in Belgium, France and Spain. Frequent co-authors include Sven Saussez, Ghanem Ghanem, Jérôme R. Lechien, Jean‐Jacques Body, Guy Laurent, Nadège Kindt, Denis Nonclercq, Géraldine Descamps, Mohammad Krayem and Ahmad Awada. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.